Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury
This study has been completed.
Study NCT00036062   Information provided by Eli Lilly and Company
First Received: May 7, 2002   Last Updated: July 18, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Lung Injury
Additional conditions recognized in this trial
Respiratory Distress Syndrome, Adult
Syndrome
More general conditions related to this trial
Disease
Lung Diseases
Pathologic Processes
Respiration Disorders
Respiratory Tract Diseases
Interventions listed in this trial
Sivelestat
Additional drug interventions recognized in this trial
ONO 5046
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Serine Proteinase Inhibitors
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services